201 related articles for article (PubMed ID: 8978368)
1. The pathobiology of biliary epithelia.
Roberts SK; Ludwig J; Larusso NF
Gastroenterology; 1997 Jan; 112(1):269-79. PubMed ID: 8978368
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma.
Celli A; Que FG
Semin Liver Dis; 1998; 18(2):177-85. PubMed ID: 9606814
[TBL] [Abstract][Full Text] [Related]
3. Protein expression of double-stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and intrahepatic cholangiocarcinoma.
Terada T; Ueyama J; Ukita Y; Ohta T
Liver; 2000 Dec; 20(6):450-7. PubMed ID: 11169059
[TBL] [Abstract][Full Text] [Related]
4. The pathology of primary biliary cirrhosis and autoimmune cholangitis.
Ludwig J
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):601-13. PubMed ID: 10976017
[TBL] [Abstract][Full Text] [Related]
5. New insights on the molecular and cell biology of human cholangiopathies.
Alvaro D; Mancino MG
Mol Aspects Med; 2008; 29(1-2):50-7. PubMed ID: 18230407
[TBL] [Abstract][Full Text] [Related]
6. New monoclonal antibodies reacting with bile ducts: further insights into the pathogenesis of bile ductular proliferation in biliary diseases.
Ayres RC; Hübscher SG; Shaw J; Garner C; Joplin R; Williams A; Neuberger JM
J Pathol; 1991 Oct; 165(2):153-61. PubMed ID: 1720818
[TBL] [Abstract][Full Text] [Related]
7. Vanishing bile duct disorders.
Desmet VJ
Prog Liver Dis; 1992; 10():89-121. PubMed ID: 1296239
[No Abstract] [Full Text] [Related]
8. The pathobiology of biliary epithelia.
Alpini G; McGill JM; Larusso NF
Hepatology; 2002 May; 35(5):1256-68. PubMed ID: 11981776
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocyte injury and ductopenic syndromes.
Xia X; Demorrow S; Francis H; Glaser S; Alpini G; Marzioni M; Fava G; Lesage G
Semin Liver Dis; 2007 Nov; 27(4):401-12. PubMed ID: 17979076
[TBL] [Abstract][Full Text] [Related]
11. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
Pinto C; Giordano DM; Maroni L; Marzioni M
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
[TBL] [Abstract][Full Text] [Related]
12. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree.
Harada K; Ohba K; Ozaki S; Isse K; Hirayama T; Wada A; Nakanuma Y
Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127
[TBL] [Abstract][Full Text] [Related]
13. Histopathology of chronic cholestasis and adult ductopenic syndrome.
Desmet VJ
Clin Liver Dis; 1998 May; 2(2):249-64, viii. PubMed ID: 15560031
[TBL] [Abstract][Full Text] [Related]
14. Precancerous lesions of intrahepatic cholangiocarcinoma.
Shimonishi T; Sasaki M; Nakanuma Y
J Hepatobiliary Pancreat Surg; 2000; 7(6):542-50. PubMed ID: 11180885
[TBL] [Abstract][Full Text] [Related]
15. Destruction of bile ducts in primary biliary cirrhosis.
Nakanuma Y; Tsuneyama K; Sasaki M; Harada K
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):549-70. PubMed ID: 10976014
[TBL] [Abstract][Full Text] [Related]
16. Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference.
Sirica AE; Nathanson MH; Gores GJ; Larusso NF
Hepatology; 2008 Dec; 48(6):2040-6. PubMed ID: 18855901
[TBL] [Abstract][Full Text] [Related]
17. Pathology and pathogenesis of intrahepatic bile duct loss.
Nakanuma Y; Tsuneyama K; Harada K
J Hepatobiliary Pancreat Surg; 2001; 8(4):303-15. PubMed ID: 11521175
[TBL] [Abstract][Full Text] [Related]
18. [A case report of cholangiectasis with cholangiocarcinoma].
Nagata T; Ikoma H; Komiyama S; Nishio M; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Sakakura C; Kokuba Y; Sonoyama T; Otsuji E
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2429-32. PubMed ID: 22202403
[TBL] [Abstract][Full Text] [Related]
19. A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes.
Hohenester S; Wenniger LM; Paulusma CC; van Vliet SJ; Jefferson DM; Elferink RP; Beuers U
Hepatology; 2012 Jan; 55(1):173-83. PubMed ID: 21932391
[TBL] [Abstract][Full Text] [Related]
20. Segmental cholangiectasia clinically worrisome for cholangiocarcinoma: comparison with recurrent pyogenic cholangitis.
Zhao L; Hosseini M; Wilcox R; Liu Q; Crook T; Taxy JB; Ferrell L; Hart J
Hum Pathol; 2015 Mar; 46(3):426-33. PubMed ID: 25600951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]